Meet Leon
Nano Science Excellence, Exemplified
We deliver novel, ready to use, validated, nano solutions that create value. Our team of experts work in collaboration with our clients and partners to deliver enhanced bioavailability, increased solubility and improved stability.
Find out moreAbout Leon
Enabling you to exploit the value of enhanced bioavailability, increased solubility and improved stability.It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon’s ‘enabling nano now’ value proposition delivers novel, ready to use, validated, nano solutions that create value for partners and meets an unmet medical need for patients.
Find out moreNews & Events
15 July 2020
Learnings from a career with its beginnings in lockdown
There are times in life when things just don’t go according to plan. Earlier this year, when I heard that I had achieved the first step in my career by securing a role at leon,
5 May 2020
leon-nanodrugs GmbH announces Dr Pascale Clement new Chief Technology Officer
The appointment strengthens scientific excellence and growth strategy leon-nanodrugs GmbH (“leon”), the Munich based nanotechnology drug development company, has recruited Dr Pascale Clement as its new Chief Technology Officer (CTO). Dr Clement joins leon from
28 April 2020
Andrea Cusack appointed Chief Executive Officer
Industry stalwart leads the nanotechnology pioneer to accelerate growth strategy. leon-nanodrugs GmbH (“leon”), the Munich based nanotechnology drug development company, has announced Andrea Cusack as its new Chief Executive Officer (CEO) and Managing Director. Cusack